CD14 and myeloid sarcoma: To determine the contribution of positive signals to the accuracy of our machine learning model, we obtain a public bulk RNA-seq dataset (GSE137143, 122 MS patients and 22 healthy donors), which consists of only CD14-positive monocytes.